These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 18410336)

  • 1. Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission.
    Kwon EJ; Yamagami J; Nishikawa T; Amagai M
    J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1070-5. PubMed ID: 18410336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins.
    Ishii K; Amagai M; Hall RP; Hashimoto T; Takayanagi A; Gamou S; Shimizu N; Nishikawa T
    J Immunol; 1997 Aug; 159(4):2010-7. PubMed ID: 9257868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
    Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
    Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
    Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH
    Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of sensitivity and specificity of enzyme-linked immunosorbent assay (ELISA) for detecting antidesmoglein 1 and 3 in Thai patients with pemphigus vulgaris and foliaceus.
    Kulkollakarn S; Wattanakrai P; Vachiramon V; Chalidapongse P
    J Med Assoc Thai; 2008 Nov; 91(11):1663-8. PubMed ID: 19127786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of desmoglein 1 and 3 enzyme-linked immunosorbent assay and direct immunofluorescence for evaluation of immunological remission in pemphigus vulgaris.
    Daneshpazhooh M; Kamyab K; Kalantari MS; Balighi K; Naraghi ZS; Shamohammadi S; Mortazavizadeh SM; Ramezani A; Chams-Davatchi C
    Clin Exp Dermatol; 2014 Jan; 39(1):41-7. PubMed ID: 23782219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.
    Abasq C; Mouquet H; Gilbert D; Tron F; Grassi V; Musette P; Joly P
    Arch Dermatol; 2009 May; 145(5):529-35. PubMed ID: 19451496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
    Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3.
    Cheng SW; Kobayashi M; Kinoshita-Kuroda K; Tanikawa A; Amagai M; Nishikawa T
    Br J Dermatol; 2002 Aug; 147(2):261-5. PubMed ID: 12174096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris.
    Sharma VK; Prasad HR; Khandpur S; Kumar A
    Int J Dermatol; 2006 May; 45(5):518-22. PubMed ID: 16700783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris.
    Zagorodniuk I; Weltfriend S; Shtruminger L; Sprecher E; Kogan O; Pollack S; Bergman R
    Int J Dermatol; 2005 Jul; 44(7):541-4. PubMed ID: 15985020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.
    Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients.
    Schmidt E; Dähnrich C; Rosemann A; Probst C; Komorowski L; Saschenbrecker S; Schlumberger W; Stöcker W; Hashimoto T; Bröcker EB; Recke A; Rose C; Zillikens D
    Exp Dermatol; 2010 May; 19(5):458-63. PubMed ID: 20163452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus.
    Ohyama M; Amagai M; Hashimoto T; Nousari HC; Anhalt GJ; Nishikawa T
    J Am Acad Dermatol; 2001 Apr; 44(4):593-8. PubMed ID: 11260531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of pemphigus autoantibodies by IIF and ELISA tests in patients with pemphigus vulgaris and foliaceus and in healthy relatives.
    Torzecka JD; Narbutt J; Sysa-Jedrzejowska A; Waszczykowska E; Lukamowicz J; Pas HH
    Med Sci Monit; 2003 Dec; 9(12):CR528-33. PubMed ID: 14646976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A higher correlation of the antibody activities against the calcium-dependent epitopes of desmoglein 3 quantified by ethylenediaminetetraacetic acid-treated enzyme-linked immunosorbent assay with clinical disease activities of pemphigus vulgaris.
    Kamiya K; Aoyama Y; Shirafuji Y; Hamada T; Morizane S; Fujii K; Iwatsuki K
    J Dermatol Sci; 2013 Jun; 70(3):190-5. PubMed ID: 23602628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption.
    Eming R; Rech J; Barth S; Kalden JR; Schuler G; Harrer T; Hertl M
    Dermatology; 2006; 212(2):177-87. PubMed ID: 16484825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of desmoglein ELISA in the clinical correlation and disease monitoring of pemphigus vulgaris.
    Anand V; Khandpur S; Sharma VK; Sharma A
    J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1377-83. PubMed ID: 21981406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.